Literature DB >> 16554154

Development of activity-based probes for trypsin-family serine proteases.

Zhengying Pan1, Douglas A Jeffery, Kareem Chehade, Jerlyn Beltman, James M Clark, Paul Grothaus, Matthew Bogyo, Amos Baruch.   

Abstract

A series of diphenylphosphonate-based probes were developed for the trypsin-like serine proteases. These probes selectively target serine proteases rather than general serine hydrolases that are targets for fluorophosphonate-based probes. This increased selectivity allows detection of low abundance serine proteases in complex proteomes using simple SDS-PAGE methods. We present here the application of multiple probes in enzyme activity profiling of intact mast cells, a type of inflammatory cell implicated in allergy and autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16554154     DOI: 10.1016/j.bmcl.2006.03.012

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  18 in total

Review 1.  The pharmacological landscape and therapeutic potential of serine hydrolases.

Authors:  Daniel A Bachovchin; Benjamin F Cravatt
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 2.  Activity-Based Probes for Proteases Pave the Way to Theranostic Applications.

Authors:  Georgia Sotiropoulou; Eleni Zingkou; Evangelos Bisyris; Georgios Pampalakis
Journal:  Pharmaceutics       Date:  2022-04-30       Impact factor: 6.525

3.  Inhibition of serine proteases by a new class of cyclosulfamide-based carbamylating agents.

Authors:  Qingliang Yang; Yi Li; Dengfeng Dou; Xiangdong Gan; Swathi Mohan; Christopher S Groutas; Laura E Stevenson; Zhong Lai; Kevin R Alliston; Jiaying Zhong; Todd D Williams; William C Groutas
Journal:  Arch Biochem Biophys       Date:  2008-04-22       Impact factor: 4.013

Review 4.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

Review 5.  Activity-based probes as a tool for functional proteomic analysis of proteases.

Authors:  Marko Fonović; Matthew Bogyo
Journal:  Expert Rev Proteomics       Date:  2008-10       Impact factor: 3.940

6.  Activity-based probes for monitoring postproline protease activity.

Authors:  Eduard Sabidó; Teresa Tarragó; Sherry Niessen; Benjamin F Cravatt; Ernest Giralt
Journal:  Chembiochem       Date:  2009-09-21       Impact factor: 3.164

7.  Protease-activated receptor-2 signaling through β-arrestin-2 mediates Alternaria alkaline serine protease-induced airway inflammation.

Authors:  Michael C Yee; Heddie L Nichols; Danny Polley; Mahmoud Saifeddine; Kasturi Pal; Kyu Lee; Emma H Wilson; Michael O Daines; Morley D Hollenberg; Scott Boitano; Kathryn A DeFea
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-18       Impact factor: 5.464

8.  Legumain is activated in macrophages during pancreatitis.

Authors:  Laura E Edgington-Mitchell; Thomas Wartmann; Alicia K Fleming; Vasilena Gocheva; Wouter A van der Linden; Nimali P Withana; Martijn Verdoes; Luigi Aurelio; Daniel Edgington-Mitchell; TinaMarie Lieu; Belinda S Parker; Bim Graham; Thomas Reinheckel; John B Furness; Johanna A Joyce; Peter Storz; Walter Halangk; Matthew Bogyo; Nigel W Bunnett
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-08-11       Impact factor: 4.052

9.  Implantation serine proteinase 1 exhibits mixed substrate specificity that silences signaling via proteinase-activated receptors.

Authors:  Navneet Sharma; Rajeev Kumar; Bernard Renaux; Mahmoud Saifeddine; Sandra Nishikawa; Koichiro Mihara; Rithwik Ramachandran; Morley D Hollenberg; Derrick E Rancourt
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

10.  Antagonism of the proinflammatory and pronociceptive actions of canonical and biased agonists of protease-activated receptor-2.

Authors:  T Lieu; E Savage; P Zhao; L Edgington-Mitchell; N Barlow; R Bron; D P Poole; P McLean; R-J Lohman; D P Fairlie; N W Bunnett
Journal:  Br J Pharmacol       Date:  2016-08-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.